Last edition
News about "TNF inhibitor biosimilar development"
Bio-Thera Expands Partnership with Intas for BAT2506 Biosimilar in India
Bio-Thera has expanded its partnership with Intas Pharmaceuticals to commercialise BAT2506, a proposed golimumab biosimilar, in India.
TNF Inhibitor Biosimilar Development | 24/03/2026 | By News Bureau | 109
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members